Metsera
Metsera is a clinical-stage biopharmaceutical company focused on developing next-generation medicines for obesity and metabolic diseases. They are advancing a portfolio of oral and injectable therapies using proprietary peptide engineering platforms like HALO™ and MOMENTUM™. Their unique value proposition lies in their ultra-long-acting peptides and innovative oral delivery systems.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: $215M
Date: 13-Nov-2024
Investors: Wellington Management, Venrock, Fidelity Management & Research Company, Janus Henderson Investors, T. Rowe Price Associates, Inc., T. Rowe Price Investment Management, Inc., Viking Global Investors, Deep Track Capital, RA Capital Management, ARCH Venture Partners, Alpha Wave Ventures, GV, SoftBank Vision Fund 2, Newpath Partners, SymBiosis
Markets: Biotechnology, Pharmaceuticals, Obesity Treatment, Metabolic Disease Treatment
HQ: New York City, New York, United States
Founded: 2022
Website: https://metsera.com
LinkedIn: https://www.linkedin.com/company/metsera/
Twitter: https://x.com/MetseraInc
Crunchbase: https://www.crunchbase.com/organization/metsera
Leave a Comment
Comments
No comments yet.